BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17708953)

  • 1. Neurofilaments and motor neuron disease.
    Julien JP
    Trends Cell Biol; 1997 Jun; 7(6):243-9. PubMed ID: 17708953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Côté F; Julien JP
    Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of degenerative neurological disease.
    Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
    Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis.
    Vechio JD; Bruijn LI; Xu Z; Brown RH; Cleveland DW
    Ann Neurol; 1996 Oct; 40(4):603-10. PubMed ID: 8871580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
    Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
    Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).
    Julien JP; Millecamps S; Kriz J
    Novartis Found Symp; 2005; 264():183-92; discussion 192-6, 227-30. PubMed ID: 15773754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium: the Darth Vader of ALS.
    Appel SH; Beers D; Siklos L; Engelhardt JI; Mosier DR
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S47-54. PubMed ID: 11465925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
    Calingasan NY; Chen J; Kiaei M; Beal MF
    Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 is a component of neurofilamentous lesions in sporadic and familial amyotrophic lateral sclerosis.
    Kato T; Kurita K; Seino T; Kadoya T; Horie H; Wada M; Kawanami T; Daimon M; Hirano A
    Biochem Biophys Res Commun; 2001 Mar; 282(1):166-72. PubMed ID: 11263987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular genetic approach to amyotrophic lateral sclerosis.
    Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
    Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathological study of familial amyotrophic lateral sclerosis with special reference to the mode of motoneuron loss in the spinal ventral horn].
    Terao S; Sobue G; Mukai E; Murakami N; Hashizume Y
    Rinsho Shinkeigaku; 1991 Sep; 31(9):960-9. PubMed ID: 1769159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropathology of the motor neuron disease--Bunina body].
    Kusaka H
    Rinsho Shinkeigaku; 1999 Jan; 39(1):65-6. PubMed ID: 10377806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications.
    Dal Canto MC
    Clin Neurosci; 1995-1996; 3(6):332-7. PubMed ID: 9021254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein in motor neuron disease: an immunohistologic study.
    Doherty MJ; Bird TD; Leverenz JB
    Acta Neuropathol; 2004 Feb; 107(2):169-75. PubMed ID: 14648076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis.
    Julien JP
    Biochem Cell Biol; 1995; 73(9-10):593-7. PubMed ID: 8714677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.